Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Classical hematology 2Sarcoma 1Plasma cell 1Myeloid 1CNS 1

Conditions

Central Nervous System Neoplasms 21Neuroblastoma 18Medulloblastoma 14Brain Neoplasms 13Astrocytoma 10Sarcoma 6Rhabdoid Tumor 6Retinoblastoma 6Ependymoma 6Oligodendroglioma 5Glioma 5Testicular Neoplasms 4Neuroectodermal Tumors, Primitive, Peripheral 4Lymphoma 4Wilms Tumor 3Teratoma 3Rhabdomyosarcoma 3Recurrence 3Pinealoma 3Ovarian Neoplasms 3Neuroectodermal Tumors, Primitive 3Liver Neoplasms 3Kidney Neoplasms 3Hepatoblastoma 3Gliosarcoma 3Glioblastoma 3Ganglioneuroblastoma 3Familial ependymoma 3Desmoplastic Small Round Cell Tumor 3Choroid Plexus Neoplasms 3

Interventions

thymoglobulin 1fosphenytoin 1fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Thiotepa 1Therapeutics 1Phenytoin 1Melphalan 1Cyclophosphamide 1Busulfan 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anemia × Thiotepa × CNS × Clear all
NCT00801931 2019-03-27

Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders

Columbia University

Phase 1/2 Terminated
1 enrolled 8 charts
CNSClassical hematologyLymphoidOther hematologic neoplasm

Anemia, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡